We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Storage and transfusion of infected autologous blood or components: a survey of North American laboratories.
- Authors
Shulman, Ira A; Osby, Melanie
- Abstract
Many patients request that autologous blood or components be collected and available for use during scheduled surgical or invasive medical procedures to avoid exposure to human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) from allogeneic transfusions. Some patients from whom autologous blood is collected are themselves infected with HIV, HBV, or HCV. However, unlike HIV-, HBV-, or HCV-infected allogeneic blood and components, which must be excluded from the community blood supply, infected autologous blood and components are allowed to be stored in hospitals and transfused back to the patients (autologous donors) from whom the blood was collected. Although the transfusion of HIV-, HBV-, or HCV-infected autologous blood or components does not present a risk to the autologous donor, such a transfusion presents a risk to other patients, considering that at least 1 in every 25,000 transfusions are administered to the wrong individual.
- Publication
Archives of pathology & laboratory medicine, 2005, Vol 129, Issue 8, p981
- ISSN
1543-2165
- Publication type
Journal Article
- DOI
10.5858/2005-129-981-SATOIA